RETENTION AGREEMENTRetention Agreement • July 3rd, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledJuly 3rd, 2017 Company Industry JurisdictionTHIS RETENTION AGREEMENT (this “Agreement”) is entered into as of the 30th day of June, 2017 (the “Effective Date”) by and between Jeff McGonegal (the “Employee”) and Bioptix, Inc., a Colorado corporation, and subsidiaries (the “Company”, and together with the Employee, the “Parties”).